AVCT

AVACTA GROUP PLC ORD 10P

TitleTime
Second Price Monitoring ExtnThu 21/05/20 | 14:05
Price Monitoring ExtensionThu 21/05/20 | 14:00
Distribution Agreement for COVID-19 Antigen TestWed 20/05/20 | 07:00
Second Price Monitoring ExtnFri 15/05/20 | 16:41
Price Monitoring ExtensionFri 15/05/20 | 16:35
Second Price Monitoring ExtnFri 15/05/20 | 14:06
Price Monitoring ExtensionFri 15/05/20 | 14:00
Second Price Monitoring ExtnFri 15/05/20 | 11:06
Price Monitoring ExtensionFri 15/05/20 | 11:00
Issue of EquityFri 15/05/20 | 09:30
SARS-COV-2 Neutralising AffimersFri 15/05/20 | 07:00
Avacta Ships SARS-COV-2 Affimer ReagentsMon 11/05/20 | 07:00
Results for the period ending 31 December 2019Wed 06/05/20 | 07:00
Holding(s) in CompanyTue 05/05/20 | 18:15
Second Price Monitoring ExtnMon 04/05/20 | 16:41
Price Monitoring ExtensionMon 04/05/20 | 16:36
COVID-19 Antigen Test Collaboration with AdeptrixFri 01/05/20 | 07:00
Holding(s) in CompanyMon 27/04/20 | 17:30
Holding(s) in CompanyMon 27/04/20 | 17:00
Holding(s) in CompanyFri 24/04/20 | 18:00
Second Price Monitoring ExtnFri 24/04/20 | 16:41
Price Monitoring ExtensionFri 24/04/20 | 16:36
Second Price Monitoring ExtnFri 24/04/20 | 14:05
Price Monitoring ExtensionFri 24/04/20 | 14:00
Second Price Monitoring ExtnThu 23/04/20 | 16:40
Price Monitoring ExtensionThu 23/04/20 | 16:35
Result of General MeetingThu 23/04/20 | 10:18
Holding(s) in CompanyWed 22/04/20 | 14:30
Second Price Monitoring ExtnWed 22/04/20 | 09:05
Price Monitoring ExtensionWed 22/04/20 | 09:00
Avacta/Cytiva Partnership Ahead of ScheduleWed 22/04/20 | 07:00
Second Price Monitoring ExtnMon 20/04/20 | 09:05
Price Monitoring ExtensionMon 20/04/20 | 09:00
Notice of Results - UpdateFri 17/04/20 | 07:00
Second Price Monitoring ExtnThu 16/04/20 | 16:41
Price Monitoring ExtensionThu 16/04/20 | 16:36
Second Price Monitoring ExtnThu 16/04/20 | 14:05
Price Monitoring ExtensionThu 16/04/20 | 14:00
Second Price Monitoring ExtnWed 15/04/20 | 09:05
Price Monitoring ExtensionWed 15/04/20 | 09:00
Holding(s) in CompanyTue 14/04/20 | 17:30
Second Price Monitoring ExtnTue 14/04/20 | 14:06
Price Monitoring ExtensionTue 14/04/20 | 14:00
Second Price Monitoring ExtnTue 14/04/20 | 11:05
Price Monitoring ExtensionTue 14/04/20 | 11:00
Second Price Monitoring ExtnThu 09/04/20 | 16:41
Price Monitoring ExtensionThu 09/04/20 | 16:37
Second Price Monitoring ExtnWed 08/04/20 | 14:05
Price Monitoring ExtensionWed 08/04/20 | 14:00
Second Price Monitoring ExtnWed 08/04/20 | 11:05
Price Monitoring ExtensionWed 08/04/20 | 11:00
Second Price Monitoring ExtnWed 08/04/20 | 09:05
Price Monitoring ExtensionWed 08/04/20 | 09:00
Avacta & Cytiva Collaborate on COVID-19 Rapid TestWed 08/04/20 | 07:00
Holding(s) in CompanyMon 06/04/20 | 17:45
Second Price Monitoring ExtnMon 06/04/20 | 14:06
Price Monitoring ExtensionMon 06/04/20 | 14:01
Proposed Placing to raise £3.75 millionMon 06/04/20 | 07:00
Appointment of Joint BrokerThu 02/04/20 | 07:01
Subscription to raise £2 millionThu 02/04/20 | 07:00
Second Price Monitoring ExtnThu 26/03/20 | 11:05
Price Monitoring ExtensionThu 26/03/20 | 11:00
Second Price Monitoring ExtnTue 24/03/20 | 14:06
Price Monitoring ExtensionTue 24/03/20 | 14:00
Second Price Monitoring ExtnMon 16/03/20 | 16:42
Price Monitoring ExtensionMon 16/03/20 | 16:38
Notice of ResultsThu 13/02/20 | 07:00
Share Incentive Plan/Issue of EquityTue 11/02/20 | 07:00
Avacta and Daewoong AgreementMon 03/02/20 | 07:00
Holding(s) in CompanyWed 29/01/20 | 14:45
Successful initial proof-of-conceptTue 28/01/20 | 07:00
Trading UpdateThu 23/01/20 | 07:00
Director AppointmentTue 21/01/20 | 07:00
Avacta and Daewoong Establish Joint VentureWed 08/01/20 | 07:00
Holding(s) in CompanyTue 26/11/19 | 09:00
Director/PDMR ShareholdingFri 22/11/19 | 08:41
LG Chem Life Sciences Expands PartnershipWed 13/11/19 | 07:00
Holding(s) in CompanyMon 11/11/19 | 07:00
Holding(s) in CompanyFri 08/11/19 | 18:30
Holding(s) in CompanyFri 08/11/19 | 18:26
Holding(s) in CompanyThu 07/11/19 | 13:00
Holding(s) in CompanyThu 07/11/19 | 11:00
Holding(s) in CompanyWed 06/11/19 | 14:30
Result of General MeetingMon 04/11/19 | 13:18
Proposed Placing & Subscription to raise up to £9MFri 18/10/19 | 12:06
Interim Results for the Period Ended 31 July 2019Fri 18/10/19 | 12:05
Collaboration with ADC TherapeuticsThu 10/10/19 | 07:00
Second Price Monitoring ExtnMon 05/08/19 | 09:05
Price Monitoring ExtensionMon 05/08/19 | 09:00
Avacta and Selexis Partner to Develop Cell LineThu 20/06/19 | 07:00
Avacta hits Clinical Candidate Selection MilestoneMon 10/06/19 | 07:00
TMAC Programme AcceleratesMon 03/06/19 | 07:00
Issue of EquityTue 23/04/19 | 15:48
Holding(s) in CompanyFri 12/04/19 | 14:46
Interim ResultsTue 09/04/19 | 07:00
Issue of EquityFri 08/03/19 | 12:14
Moderna Exercises Exclusive Product License OptionMon 04/02/19 | 07:00
Director AppointmentMon 28/01/19 | 07:00
Result of Annual General MeetingMon 21/01/19 | 15:40
AGM Business Update and Notice of ResultsMon 21/01/19 | 07:00
Share Incentive Plan/Issue of EquityFri 18/01/19 | 17:08
Change of accounting reference dateFri 18/01/19 | 10:00
Holding(s) in CompanyWed 09/01/19 | 11:06
Director/PDMR ShareholdingsMon 07/01/19 | 14:50
Holding(s) in CompanyThu 03/01/19 | 08:56
Director/PDMR ShareholdingWed 02/01/19 | 07:00
Holding(s) in CompanyFri 21/12/18 | 13:41
Holding(s) in CompanyWed 19/12/18 | 15:32
Holding(s) in CompanyWed 12/12/18 | 12:50
Holding(s) in CompanyWed 12/12/18 | 12:44
Appointment of Chief Medical OfficerWed 12/12/18 | 07:00
Posting of Annual Report and Notice of AGMTue 11/12/18 | 07:00
Second Price Monitoring ExtnMon 10/12/18 | 14:05
Price Monitoring ExtensionMon 10/12/18 | 14:00
Development Partnership with LG Chem Life SciencesMon 10/12/18 | 07:00
Avacta agrees Affimer reagent licensing dealWed 10/10/18 | 07:00
Preliminary ResultsTue 02/10/18 | 07:00
Notice of ResultsWed 05/09/18 | 07:00
Holding(s) in CompanyFri 31/08/18 | 09:55
Holding(s) in CompanyThu 23/08/18 | 17:07
Holding(s) in CompanyThu 23/08/18 | 17:06
Holding(s) in CompanyThu 23/08/18 | 11:21
Holding(s) in CompanyWed 22/08/18 | 14:23
Holding(s) in CompanyWed 22/08/18 | 09:20
Result of General MeetingFri 17/08/18 | 11:30
Holding(s) in CompanyMon 06/08/18 | 16:24
Results of Placing and SubscriptionMon 30/07/18 | 18:06
Proposed Placing and Subscription to raise £11.4mMon 30/07/18 | 11:41
Major Therapeutics Co-development PartnershipTue 24/07/18 | 07:00
Appointment of Non-Executive ChairmanMon 11/06/18 | 07:00
Successful Outcome of Study with FIT BiotechTue 22/05/18 | 07:00
Holding(s) in CompanyMon 30/04/18 | 16:45
Interim ResultsMon 16/04/18 | 07:25
Issue of EquityMon 09/04/18 | 14:58
Directorate ChangeThu 29/03/18 | 07:00
Director/PDMR ShareholdingTue 13/03/18 | 12:02
Price Monitoring ExtensionWed 07/03/18 | 16:35
Avacta and OncoSec to CollaborateMon 22/01/18 | 07:00
Result of Annual General MeetingThu 18/01/18 | 11:26
AGM Business Update and Notice of ResultsThu 18/01/18 | 07:00
Drug Development Partnership with GlytheraMon 15/01/18 | 07:00
PDMR Dealing and Issue of EquityThu 04/01/18 | 11:04
Issue of EquityMon 18/12/17 | 16:28
Posting of Annual Report and Notice of AGMMon 04/12/17 | 11:03
Issue of EquityThu 30/11/17 | 10:57
Holding(s) in CompanyTue 14/11/17 | 15:27
Director Dealing and Issue of EquityMon 09/10/17 | 16:02
Research collaboration with FIT Biotech OyThu 05/10/17 | 07:00
Preliminary ResultsWed 04/10/17 | 07:00
Avacta establishes US business development teamMon 02/10/17 | 07:00
Notice of ResultsThu 07/09/17 | 07:00
Director/PDMR ShareholdingMon 21/08/17 | 12:00
Trading UpdateMon 07/08/17 | 07:00
Issue of EquityMon 31/07/17 | 12:00
Director/PDMR ShareholdingFri 28/07/17 | 13:15
Director Dealing and Issue of EquityWed 05/07/17 | 07:00